Aspirin treatment and risk of first incident cardiovascular diseases in patients with type 2 diabetes: an observational study from the Swedish National Diabetes Register

Item

http://www.wikidata.org/entity/Q36809851

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Aspirin treatment and risk of ...... ish National Diabetes Register

@ast

Aspirin treatment and risk of ...... ish National Diabetes Register

@en

type

Item

label

Aspirin treatment and risk of ...... ish National Diabetes Register

@ast

Aspirin treatment and risk of ...... ish National Diabetes Register

@en

prefLabel

Aspirin treatment and risk of ...... ish National Diabetes Register

@ast

Aspirin treatment and risk of ...... ish National Diabetes Register

@en

P1476

Aspirin treatment and risk of ...... ish National Diabetes Register

@en

P2093

Ann-Marie Svensson

http://www.w3.org/2001/XMLSchema#string

Björn Eliasson

http://www.w3.org/2001/XMLSchema#string

Eva Fhärm

http://www.w3.org/2001/XMLSchema#string

Jan Cederholm

http://www.w3.org/2001/XMLSchema#string

Nils Ekström

http://www.w3.org/2001/XMLSchema#string

Olov Rolandsson

http://www.w3.org/2001/XMLSchema#string

P2860

Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American Co

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

Aspirin for the primary prevention of cardiovascular events: a systematic review and meta-analysis comparing patients with and without diabetes.

Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials.

Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial.

Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trials.

P31

scholarly article

P356

10.1136/BMJOPEN-2013-002688

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Björn Zethelius

Soffia Gudbjörnsdottir

Mervete Miftaraj

P577

2013-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236253029

http://www.w3.org/2001/XMLSchema#string

P698

23604419

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

cardiovascular disease

P932

3641436

http://www.w3.org/2001/XMLSchema#string